Combination of ALOX12 inhibitors (baicalein and BMD122) and radiation therapy have synergistic inhibitory effects on the growth of LNCaP and PC-3 prostate cancer cells as well as prostate cancer xenografts in SCID mice [237]. This evidence concerns the gene ALOX12 and prostate carcinoma.